Aldeyra Therapeutics, Inc. (ALDX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 66.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -66.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 3.48M | 6.67M | 8M | 10.17M | 10.43M | 16.58M | 16.14M | 18.01M | 9.39M | 6.1M | 9.55M | 10.34M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.14T | 2.36M | 2.57M | 1.66M | 3M | 1.95M | 3.7M | 3.04M | 3.21M | 1.8M | 2.59M | 3.38M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.41M | 4.3M | 5.43M | 8.51M | 7.42M | 14.63M | 12.44M | 14.97M | 6.18M | 4.3M | 6.96M | 6.96M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.55M | -6.67M | -8M | -10.17M | -10.43M | -16.58M | -16.14M | -18.01M | -9.39M | -6.1M | -9.55M | -10.34M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 65.98% | 59.78% | 50.42% | 43.53% | -11% | -171.87% | -68.97% | -74.11% | 44.09% | 55.48% | 35.4% | 41.62% |
| EBITDA | -3.48M | -6.6M | -7.94M | -10.11M | -10.37M | -16.51M | -16.07M | -17.95M | -9.33M | -6.03M | -9.49M | -10.28M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 66.43% | 60.02% | 50.62% | 43.68% | -11.07% | -173.79% | -69.47% | -74.6% | 44.23% | 55.75% | 35.56% | 41.77% |
| D&A (Non-Cash Add-back) | 66.6K | 65.12K | 63.68K | 62.28K | 60.91K | 64.37K | 62.99K | 61.63K | 60.63K | 66.47K | 65K | 64.34K |
| EBIT | -3.55M | -5.99M | -7.21M | -9.3M | -9.45M | -15.34M | -14.63M | -16.37M | -7.58M | -4.24M | -7.65M | -8.46M |
| Net Interest Income | 94.3K | 206.38K | 312.79K | 401.42K | 497.96K | 769.02K | 1.02M | 1.16M | 1.31M | 1.34M | 1.36M | 1.36M |
| Interest Income | 562.98K | 681.63K | 788.69K | 872.04K | 981.49K | 1.24M | 1.5M | 1.64M | 1.81M | 1.86M | 1.9M | 1.88M |
| Interest Expense | 468.68K | 475.26K | 475.9K | 470.62K | 483.53K | 470.86K | 479.25K | 477.6K | 498.53K | 514.26K | 538.74K | 527.14K |
| Other Income/Expense | 94.3K | 206.38K | 312.79K | 401.42K | 497.96K | 769.02K | 1.02M | 1.16M | 1.31M | 1.34M | 1.36M | 1.36M |
| Pretax Income | -3.45M | -6.46M | -7.69M | -9.77M | -9.93M | -15.81M | -15.11M | -16.85M | -8.08M | -4.75M | -8.19M | -8.99M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.45M | -6.46M | -7.69M | -9.77M | -9.93M | -15.81M | -15.11M | -16.85M | -8.08M | -4.75M | -8.19M | -8.99M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 65.23% | 59.13% | 49.13% | 42.03% | -22.86% | -232.61% | -84.6% | -87.47% | 48.24% | 63.16% | 43.75% | 49.46% |
| Net Income (Continuing) | -3.45M | -6.46M | -7.69M | -9.77M | -9.93M | -15.81M | -15.11M | -16.85M | -8.08M | -4.75M | -8.19M | -8.99M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.06 | -0.11 | -0.13 | -0.16 | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 | -0.08 | -0.14 | -0.15 |
| EPS Growth % | 66.35% | 59.26% | 48% | 42.86% | -21.43% | -236.24% | -78.57% | -86.67% | 48.15% | 63.5% | 41.67% | 51.61% |
| EPS (Basic) | -0.06 | -0.11 | -0.13 | -0.16 | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 | -0.08 | -0.14 | -0.15 |
| Diluted Shares Outstanding | 60.32M | 60.16M | 60.13M | 60.05M | 59.89M | 59.48M | 59.53M | 59.41M | 59.41M | 59.2M | 58.99M | 58.79M |
| Basic Shares Outstanding | 60.32M | 60.16M | 60.13M | 60.05M | 59.89M | 59.48M | 59.53M | 59.41M | 59.41M | 59.2M | 58.99M | 58.79M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |